AstraZeneca PLC operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares AstraZeneca PLC with three other
pharmaceutical manufacturers in Europe:
Novo Nordisk As
sales of 126.95 billion Danish Kroner [US$20.59 billion]
of which 85%
was Diabetes and obesity),
(£34.10 billion [US$47.56 billion]
based in FRANCE
(37.37 billion Euros [US$45.08 billion]
During the year ended December of 2020, sales at
AstraZeneca PLC were £20.59 billion (US$28.72 billion).
increase of 8.0%
versus 2019, when the company's sales were £19.06 billion.